Evaluation of a clinical protocol for the management of fever in labor among pregnant women at term: A quality-improvement study.


Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
Apr 2023
Historique:
revised: 02 09 2022
received: 24 05 2022
accepted: 25 09 2022
pubmed: 2 10 2022
medline: 17 3 2023
entrez: 1 10 2022
Statut: ppublish

Résumé

To assess the impact of a quality-improvement initiative designed to increase diagnostic accuracy and adequate management of clinical chorioamnionitis (CC) at a tertiary center. Chorioamnionitis occurs in 1%-13% of term pregnancies and increases maternal and neonatal peripartum complications; often over-diagnosed, it leads to unnecessary investigations and treatments. This was an interrupted time-series study. In September 2017 two interventions were implemented: (1) staff training and (2) standardized clinical protocol for the management of fever in labor. All singleton term pregnancies were included. CC cases were reviewed in the pre-intervention (2015-2016, n = 179) and post-intervention (2017-2018, n = 142) groups. CC criteria based on the American College of Obstetricians and Gynecologists guidelines, antibiotics, maternal and neonatal outcomes, and pathology were compared. A cost-consequence analysis was performed. Incidence of CC decreased from 8.2 to 5.6 per 10 person-year (P < 0.001). This was associated with a significant increase in diagnostic accuracy from 15.7% to 73.2% (P < 0.001). Weight-adjusted tobramycin dosage improved from 8.8% to 69.1% (P < 0.001). Maternal length of hospitalization and readmissions decreased significantly, without affecting neonatal sepsis rate. Interventions decreased yearly hospital costs associated with CC by 23.4%. Standardizing the management of fever in labor significantly increased the diagnostic accuracy of CC and decreased the misuse of antibiotics in term pregnancies. CC costs decreased by 23.4%.

Identifiants

pubmed: 36181701
doi: 10.1002/ijgo.14488
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

225-233

Subventions

Organisme : Canadian Institutes for Health Research

Informations de copyright

© 2022 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

Références

Tita A, Andrews W. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010;37(2):339-354.
Gibbs RS, Duff P. Progress in pathogenesis and management of clinical intraamniotic infection. Am J Obstet Gynecol. 1991;164(5 Pt 1):1317-1326.
Newton ER, Prihoda TJ, Gibbs RS. Logistic regression analysis of risk factors for intra-amniotic infection. Obstet Gynecol. 1989;73(4):571-575.
Money D, Allen V. Society of Obstetrics and Gynecology of Canada. The prevention of early-onset neonatal group B streptococcal disease. J Obstet Gynaecol Can. 2013;35(10):939-951.
Jefferies A, Canadian Paediatric Society. Management of term infants at increased risk for early onset bacterial sepsis. Paediatr Child Health. 2017;22(4):223-228.
Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30(11):937-941.
Jackson G, Rawiki P, Sendelbach D, Manning M, Engle W. Hospital course and short-term outcomes of term and late preterm neonates following exposure to prolonged rupture of membranes and/or chorioamnionitis. Pediatr Infect Dis J. 2012;31(1):89-90.
Higgins RD, Saade G, Polin RA, et al. Evaluation and Management of Women and Newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol. 2016;127(3):426-436.
Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis. 1982;145(1):1-8.
Sung JH, Choi SJ, Oh SY, Roh CR. Should the diagnostic criteria for suspected clinical chorioamnionitis be changed? J Matern Fetal Neonatal Med. 2019;34:1-10.
Curtin WM, Katzman PJ, Florescue H, Metlay LA. Accuracy of signs of clinical chorioamnionitis in the term parturient. J Perinatol. 2013;33(6):422-428.
Romero R, Miranda J, Kusanovic JP, et al. Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques. J Perinat Med. 2015;43(1):19-36.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
Langley GLMR, Nolan KM, Nolan TW, Norman CL, Provost LP. The improvement guide: a practical approach to enhancing organizational performance. 2nd ed. Jossey-Bass Publishers; 2009.
Black LP, Hinson L, Duff P. Limited course of antibiotic treatment for chorioamnionitis. Obstet Gynecol. 2012;119(6):1102-1105.
Edwards RK, Duff P. Single additional dose postpartum therapy for women with chorioamnionitis. Obstet Gynecol. 2003;102(5 Pt 1):957-961.
Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol. 1993;36(4):795-808.
Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140(7):698-713.
Jacobs PBA, Lee KM. Guidance document for the costing of health care resources in the Canadian setting, [CADTH Website] 2016. https://www.cadth.ca/sites/default/files/pdf/CP0009_CADTHCostingGuidance.pdf. Accessed May 13th 2022.
Charpentier C, McDonald S, Elwood C, et al. A survey on variation in diagnosis and treatment of chorioamnionitis in tertiary Centres in Canada. J Obstet Gynaecol Can. 2021;4(1):28-33.
Greenberg MB, Anderson BL, Schulkin J, Norton ME, Aziz N. A first look at chorioamnionitis management practice variation among US obstetricians. Infect Dis Obstet Gynecol. 2012;2012:628362.
Chiruvolu A, Petrey B, Stanzo KC, Daoud Y. An institutional approach to the Management of Asymptomatic Chorioamnionitis-Exposed Infants Born >/=35 weeks gestation. Pediatr Qual Saf. 2019;4(6):e238.
Joshi NS, Gupta A, Allan JM, et al. Management of chorioamnionitis-exposed infants in the newborn nursery using a clinical examination-based approach. Hosp Pediatr. 2019;9(4):227-233.
Aziz F, Salafia C, Rothschild T, Akinnawonu F, Fuks A. 476: Association of clinical chorioamnionitis with histological evidence of maternal or fetal inflammatory response. Am J Obstet Gynecol. 2014;210(1):S238.
Suzuki S. Association between clinical chorioamnionitis and histological funisitis at term. J Neonatal Perinatal Med. 2019;12(1):37-40.

Auteurs

Elisabeth Spénard (E)

Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Québec, Canada.

Laurent Tordjman (L)

Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Québec, Canada.
Department of Obstetrics and Gynecology, Hôpital Maisonneuve-Rosemont, CIUSSS EMTL, Montreal, Québec, Canada.

Ann-Elisabeth Marrié-Mas (AE)

Department of Pathology, Hôpital Maisonneuve-Rosemont, CIUSSS EMTL, Montreal, Québec, Canada.

Dorothee Dal Soglio (D)

Department of Pathology, CHU Sainte-Justine, Montreal, Québec, Canada.

Alexa Eberle (A)

Department of Medicine, Université de Montréal, Montreal, Québec, Canada.

Annie-Claude Labbé (AC)

Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Québec, Canada.
Service of Infectious Diseases, Hôpital Maisonneuve-Rosemont, CIUSSS EMTL, Montreal, Québec, Canada.

Isabelle Boucoiran (I)

Department of Obstetrics and Gynecology, Université de Montréal, Montreal, Québec, Canada.
Mother and Child Infectious Disease Centre, Department of Obstetrics and Gynecology, CHU Sainte-Justine, Montreal, Québec, Canada.
School of Public Health, Université de Montréal, Montreal, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH